GSTZ1

glutathione S-transferase zeta 1, the group of Soluble glutathione S-transferases

Basic information

Region (hg38): 14:77320996-77331597

Links

ENSG00000100577NCBI:2954OMIM:603758HGNC:4643Uniprot:O43708AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • maleylacetoacetate isomerase deficiency (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Maleylacetoacetate isomerase deficiencyARGeneralThe clinical relevance of the condition is unclearBiochemical27876694

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GSTZ1 gene.

  • not_specified (28 variants)
  • Maleylacetoacetate_isomerase_deficiency (7 variants)
  • GSTZ1-related_disorder (6 variants)
  • not_provided (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GSTZ1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000145870.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
missense
1
clinvar
27
clinvar
2
clinvar
30
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
2
clinvar
2
Total 2 2 29 3 0

Highest pathogenic variant AF is 0.00072983385

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GSTZ1protein_codingprotein_codingENST00000216465 910714
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.51e-110.06231256960521257480.000207
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.01471261261.000.000006841391
Missense in Polyphen2835.3120.79293448
Synonymous-0.5945448.71.110.00000288424
Loss of Function0.08251616.40.9789.33e-7165

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006030.000597
Ashkenazi Jewish0.0003150.000298
East Asian0.0002170.000217
Finnish0.000.00
European (Non-Finnish)0.0001610.000158
Middle Eastern0.0002170.000217
South Asian0.0003070.000294
Other0.0004890.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Bifunctional enzyme showing minimal glutathione- conjugating activity with ethacrynic acid and 7-chloro-4- nitrobenz-2-oxa-1,3-diazole and maleylacetoacetate isomerase activity. Has also low glutathione peroxidase activity with T- butyl and cumene hydroperoxides. Is able to catalyze the glutathione dependent oxygenation of dichloroacetic acid to glyoxylic acid. {ECO:0000269|PubMed:10739172}.;
Pathway
Tyrosine metabolism - Homo sapiens (human);Tyrosinemia, transient, of the newborn;Dopamine beta-hydroxylase deficiency;Disulfiram Action Pathway;Phenylalanine and Tyrosine Metabolism;Tyrosine Metabolism;Alkaptonuria;Monoamine oxidase-a deficiency (MAO-A);Hawkinsinuria;Tyrosinemia Type I;Phenylketonuria;Tyrosinemia Type 3 (TYRO3);Tyrosinemia Type 2 (or Richner-Hanhart syndrome);Metapathway biotransformation Phase I and II;Glutathione conjugation;Phase II - Conjugation of compounds;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;glutathione-mediated detoxification;Metabolism of amino acids and derivatives;The citric acid (TCA) cycle and respiratory electron transport;Androgen and estrogen biosynthesis and metabolism;Leukotriene metabolism;Phenylalanine and tyrosine catabolism;Biological oxidations;Metabolism;tyrosine degradation;Prostaglandin formation from arachidonate;Tryptophan metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Xenobiotics metabolism;Tyrosine metabolism;Arachidonic acid metabolism (Consensus)

Recessive Scores

pRec
0.305

Intolerance Scores

loftool
0.929
rvis_EVS
0.95
rvis_percentile_EVS
90.01

Haploinsufficiency Scores

pHI
0.175
hipred
N
hipred_score
0.251
ghis
0.404

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.269

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumHigh

Mouse Genome Informatics

Gene name
Gstz1
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; renal/urinary system phenotype; immune system phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Gene ontology

Biological process
L-phenylalanine catabolic process;tyrosine catabolic process;glutathione metabolic process;regulation of acetyl-CoA biosynthetic process from pyruvate;cellular oxidant detoxification;glutathione derivative biosynthetic process
Cellular component
mitochondrion;mitochondrial matrix;cytosol
Molecular function
glutathione transferase activity;glutathione peroxidase activity;protein binding;maleylacetoacetate isomerase activity;hydrolase activity, acting on acid halide bonds, in C-halide compounds;identical protein binding;protein homodimerization activity